721 related articles for article (PubMed ID: 18809237)
1. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
2. A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation.
Yeh CH; Peng HC; Yih JB; Huang TF
Biochim Biophys Acta; 1998 Nov; 1425(3):493-504. PubMed ID: 9838213
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
Okuda D; Morita T
J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
[TBL] [Abstract][Full Text] [Related]
4. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
5. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis.
Yeh CH; Peng HC; Huang TF
Blood; 1998 Nov; 92(9):3268-76. PubMed ID: 9787163
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
8. Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways.
Dorsam RT; Kim S; Murugappan S; Rachoor S; Shankar H; Jin J; Kunapuli SP
Blood; 2005 Apr; 105(7):2749-56. PubMed ID: 15546949
[TBL] [Abstract][Full Text] [Related]
9. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
10. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
12. Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation.
Clark EA; Trikha M; Markland FS; Brugge JS
J Biol Chem; 1994 Sep; 269(35):21940-3. PubMed ID: 7520909
[TBL] [Abstract][Full Text] [Related]
13. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
14. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
[TBL] [Abstract][Full Text] [Related]
15. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3.
Pampolina C; McNicol A
Thromb Haemost; 2005 May; 93(5):932-9. PubMed ID: 15886812
[TBL] [Abstract][Full Text] [Related]
17. A Novel α
Kuo YJ; Chung CH; Pan TY; Chuang WJ; Huang TF
Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877725
[TBL] [Abstract][Full Text] [Related]
18. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway.
Chung CH; Peng HC; Huang TF
Biochem Biophys Res Commun; 2001 Jul; 285(3):689-95. PubMed ID: 11453648
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
Marciniak SJ; Jordan RE; Mascelli MA
Thromb Haemost; 2001 Mar; 85(3):539-43. PubMed ID: 11307828
[TBL] [Abstract][Full Text] [Related]
20. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
